Alpha‐synuclein RT ‐Qu IC in the CSF of patients with alpha‐synucleinopathies
Western General Hospital · University of Edinburgh · +2 more institutions
Abstract
We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful…
Citation impact
- FWCI
- 23.64
- Percentile
- 100%
- References
- 20
Authors
16- GFGraham Fairfoul
Western General Hospital, University of Edinburgh
- LILynne I. McGuire
Western General Hospital, University of Edinburgh
- SPSuvankar Pal
Western General Hospital, University of Edinburgh
- JWJames W. Ironside
Western General Hospital, University of Edinburgh
- JNJuliane Neumann
John Radcliffe Hospital, University of Oxford
Topics & keywords
- Synucleinopathies
- Medicine
- Alpha (finance)
- Alpha-synuclein
- Internal medicine
- Parkinson's disease
- Disease
Funding
- MJMichael J. Fox Foundation for Parkinson's ResearchAward: R43828
- SGScottish Government
- ASAlzheimer Society
- NINational Institute for Health and Care Research
- DODepartment of Health and Social Care
- PUParkinson's UK
- UOUniversity of Oxford
- SOScottish Office Home and Health DepartmentAward: R43401
- OPOtsuka Pharmaceutical Development and Commercialization
- MRMedical Research CouncilAwards: G1000681, MR/L022656/1
- NONIHR Oxford Biomedical Research Centre